Rubenstein David M. — SEC insider filings
SEC reporting owner CIK 1543895. 16 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2020-11-10 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 11 filings — 19,275,000 shares, $779,458,338 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 2,000,000 shares @ $58.00 ($116,000,000) in Carlyle Group Inc., filed 2021-11-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Carlyle Group Inc. (CG) | Director | 11 | — | 13 legs · 19,275,000 sh · $779,458,338 | 3 |
| Moderna, Inc. (MRNA) | Director | 5 | — | — | 14 |
Insider filings — Rubenstein David M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Carlyle Group Inc. (CG) | Gift (G): 100,000 @ $0 · Sale (S): 400,000 @ $42.74 | EDGAR |
| 2026-05-08 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 9,681 (derivative) @ $0 · Grant/award (A): 2,092 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 8,116 · Option exercise (M): 8,116 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Carlyle Group Inc. (CG) | Gift (G): 100,000 @ $0 · Sale (S): 500,000 @ $46.68 | EDGAR |
| 2025-12-12 | 4 | Carlyle Group Inc. (CG) | Gift (G): 625,000 @ $0 · Sale (S): 625,000 @ $56.55 | EDGAR |
| 2025-08-06 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 850 · Option exercise (M): 850 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 677 · Option exercise (M): 677 (derivative) @ $0 · Grant/award (A): 12,756 (derivative) @ $0 · Grant/award (A): 8,116 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 5,051 (derivative) @ $0 · Grant/award (A): 4,065 (derivative) @ $0 · Grant/award (A): 850 (derivative) @ $0 · Grant/award (A): 677 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,000,000 @ $38.67 | EDGAR |
| 2021-11-10 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,000,000 @ $58 | EDGAR |
| 2021-08-13 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,100,000 @ $46.46 · Sale (S): 1,895,200 @ $47.80 · Sale (S): 4,800 @ $48.86 | EDGAR |
| 2021-05-19 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,000,000 @ $41.76 | EDGAR |
| 2021-03-12 | 4 | Carlyle Group Inc. (CG) | Sale (S): 3,000,000 @ $35.80 | EDGAR |
| 2020-12-11 | 4 | Carlyle Group Inc. (CG) | Sale (S): 750,000 @ $29.05 | EDGAR |
| 2020-11-24 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,000,000 @ $27.30 | EDGAR |
| 2020-11-10 | 4 | Carlyle Group Inc. (CG) | Sale (S): 2,000,000 @ $27.32 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1543895 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs